• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV 合并 COVID-19 患者的细菌合并感染、机会性疾病和持续免疫抑制的风险较低。

Low risk of bacterial co-infection, opportunistic diseases, and persistent immunosuppression in people living with HIV and COVID-19.

机构信息

HIV-Unit, Department of Infectious Diseases, Ramon y Cajal Hospital, Cra Colmenar Km 9.1, 28034, Madrid, Spain.

Laboratory of Immunovirology, Infectious Diseases, Ramon y Cajal Hospital, Madrid, Spain.

出版信息

Infection. 2022 Aug;50(4):1013-1017. doi: 10.1007/s15010-022-01811-0. Epub 2022 Mar 31.

DOI:10.1007/s15010-022-01811-0
PMID:35357656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8968266/
Abstract

PURPOSE

SARS-CoV-2 infection produces lymphopenia and CD4+ T-cell decrease, which could lead to a higher risk of bacterial co-infection or impair immunological evolution in people living with HIV (PLWH).

METHODS

We investigated the rate of co-infection and superinfection, and the evolution of CD4+ count and CD4+/CD8+ ratio, in hospitalized PLWH with COVID-19.

RESULTS

From March to December 2020, 176 PLWH had symptomatic COVID-19 and 62 required hospitalization (median age, 56 years, 89% males). At admission, 7% and 13% of patients had leukocytosis or increased procalcitonin values and 37 (60%) received empiric antibiotic therapy, but no bacterial co-infection was diagnosed. There were seven cases of superinfection (12%), and one case of P. jiroveci pneumonia during ICU stay. No significant change in CD4+ count or CD4+/CD8+ ratio was observed after discharge.

CONCLUSION

Bacterial co-infection is not frequent in PLWH with COVID-19. Immune recovery is observed in most of patients after the disease.

摘要

目的

SARS-CoV-2 感染可导致淋巴细胞减少和 CD4+T 细胞减少,这可能导致 HIV 感染者(PLWH)发生细菌合并感染的风险增加或免疫进化受损。

方法

我们研究了住院 COVID-19 合并感染和再感染的 PLWH 中 CD4+计数和 CD4+/CD8+比值的演变。

结果

2020 年 3 月至 12 月,176 例 PLWH 出现有症状的 COVID-19,62 例需要住院治疗(中位年龄 56 岁,89%为男性)。入院时,7%和 13%的患者白细胞增多或降钙素原升高,37 例(60%)接受经验性抗生素治疗,但未诊断细菌合并感染。有 7 例再感染(12%),1 例在 ICU 期间发生肺孢子菌肺炎。出院后 CD4+计数或 CD4+/CD8+比值无明显变化。

结论

COVID-19 合并感染的 PLWH 中细菌合并感染不常见。大多数患者在疾病后观察到免疫恢复。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a9/8968266/5e902ee4dd3a/15010_2022_1811_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a9/8968266/5e902ee4dd3a/15010_2022_1811_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a9/8968266/5e902ee4dd3a/15010_2022_1811_Fig1_HTML.jpg

相似文献

1
Low risk of bacterial co-infection, opportunistic diseases, and persistent immunosuppression in people living with HIV and COVID-19.HIV 合并 COVID-19 患者的细菌合并感染、机会性疾病和持续免疫抑制的风险较低。
Infection. 2022 Aug;50(4):1013-1017. doi: 10.1007/s15010-022-01811-0. Epub 2022 Mar 31.
2
Comparison of platelet-and endothelial-associated biomarkers of disease activity in people hospitalized with Covid-19 with and without HIV co-infection.比较合并和不合并 HIV 感染的住院 COVID-19 患者血小板和内皮相关疾病活动生物标志物。
Front Immunol. 2023 Aug 14;14:1235914. doi: 10.3389/fimmu.2023.1235914. eCollection 2023.
3
Clinical outcomes and immunological response to SARS-CoV-2 infection among people living with HIV.HIV 感染者感染 SARS-CoV-2 的临床结局和免疫反应。
Exp Biol Med (Maywood). 2024 Apr 2;249:10059. doi: 10.3389/ebm.2024.10059. eCollection 2024.
4
The clinical and epidemiological characteristics of a series of patients living with HIV admitted for COVID-19 in a district hospital.在一家地区医院因 COVID-19 住院的一系列 HIV 感染者的临床和流行病学特征。
BMC Infect Dis. 2023 Feb 28;23(1):123. doi: 10.1186/s12879-023-08004-6.
5
Immune deficiency is a risk factor for severe COVID-19 in people living with HIV.免疫缺陷是 HIV 感染者发生重症 COVID-19 的一个风险因素。
HIV Med. 2021 May;22(5):372-378. doi: 10.1111/hiv.13037. Epub 2020 Dec 27.
6
Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.比利时 HIV 感染者 COVID-19 的临床特征和结局:一项多中心、回顾性队列研究。
J Med Virol. 2021 May;93(5):2971-2978. doi: 10.1002/jmv.26828. Epub 2021 Feb 9.
7
Higher intensive care unit consultations for COVID-19 patients living with HIV compared to those without HIV coinfection in Uganda.在乌干达,与未合并感染艾滋病毒的新冠肺炎患者相比,感染艾滋病毒的新冠肺炎患者接受重症监护病房会诊的次数更多。
J Med Virol. 2022 Sep;94(9):4294-4300. doi: 10.1002/jmv.27887. Epub 2022 Jun 2.
8
Presentation and outcome of COVID-19 in HIV patients with high viral loads and opportunistic infections: a case series.高病毒载量和机会性感染的HIV患者中COVID-19的表现及结局:病例系列
Ghana Med J. 2020 Dec;54(4 Suppl):121-124. doi: 10.4314/gmj.v54i4s.20.
9
Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.在荷兰的一项多中心回顾性队列研究中,COVID-19 住院患者早期的细菌合并感染较少,但经验性抗生素使用频繁。
Infect Dis (Lond). 2021 Feb;53(2):102-110. doi: 10.1080/23744235.2020.1839672. Epub 2020 Oct 24.
10
Driving force of COVID-19 among people living with HIV in Wuhan, China.中国武汉 HIV 感染者中 COVID-19 的驱动因素。
AIDS Care. 2022 Nov;34(11):1364-1371. doi: 10.1080/09540121.2022.2052259. Epub 2022 Mar 23.

引用本文的文献

1
Clinical prognostic value of TTV and HCMV but not EBV for outcomes in hospitalized HIV-positive patients.TTV和HCMV而非EBV对住院HIV阳性患者预后的临床预测价值。
Biosaf Health. 2025 May 16;7(3):173-182. doi: 10.1016/j.bsheal.2025.05.006. eCollection 2025 Jun.
2
Molecular pathogen profiling of COVID-19 coinfections.新冠病毒合并感染的分子病原体分析
BMC Infect Dis. 2024 Dec 19;24(1):1451. doi: 10.1186/s12879-024-10347-7.
3
Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease.

本文引用的文献

1
Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System.CD4+ T 细胞损耗共享:当 COVID-19 和 HIV 在免疫系统上交锋时。
Front Immunol. 2020 Dec 15;11:596631. doi: 10.3389/fimmu.2020.596631. eCollection 2020.
2
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.COVID-19 住院患者合并感染和再感染的发生率:一项回顾性队列研究。
Clin Microbiol Infect. 2021 Jan;27(1):83-88. doi: 10.1016/j.cmi.2020.07.041. Epub 2020 Jul 31.
3
Antimicrobial use, drug-resistant infections and COVID-19.
炎症性肠病患者全国队列的严重和机会性感染风险,以及 SARS-COV-2 对这种风险的影响。
Aliment Pharmacol Ther. 2023 Apr;57(7):800-807. doi: 10.1111/apt.17393. Epub 2023 Jan 16.
抗菌药物使用、耐药菌感染与新冠病毒。
Nat Rev Microbiol. 2020 Aug;18(8):409-410. doi: 10.1038/s41579-020-0395-y.
4
Co-infections in people with COVID-19: a systematic review and meta-analysis.COVID-19 患者合并感染:系统评价和荟萃分析。
J Infect. 2020 Aug;81(2):266-275. doi: 10.1016/j.jinf.2020.05.046. Epub 2020 May 27.
5
COVID-19 and the potential long-term impact on antimicrobial resistance.COVID-19 与潜在的长期抗菌药物耐药性影响
J Antimicrob Chemother. 2020 Jul 1;75(7):1681-1684. doi: 10.1093/jac/dkaa194.
6
A Case of COVID-19 and Coinfection.一例新型冠状病毒肺炎合并感染病例
Am J Respir Crit Care Med. 2020 Jul 1;202(1):136-138. doi: 10.1164/rccm.202003-0766LE.
7
Bacteremia and Blood Culture Utilization during COVID-19 Surge in New York City.纽约市新冠疫情高峰期的菌血症与血培养利用情况
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00875-20.
8
Clinical features and treatment of COVID-19 patients in northeast Chongqing.重庆东北部地区 COVID-19 患者的临床特征和治疗方法。
J Med Virol. 2020 Jul;92(7):797-806. doi: 10.1002/jmv.25783. Epub 2020 Apr 1.
9
Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis.降钙素原 (PCT) 水平对 ICU 流感患者合并细菌感染的排除诊断:CHAID 决策树分析。
J Infect. 2016 Feb;72(2):143-51. doi: 10.1016/j.jinf.2015.11.007. Epub 2015 Dec 15.
10
Bacterial and viral infections associated with influenza.与流感相关的细菌和病毒感染。
Influenza Other Respir Viruses. 2013 Sep;7 Suppl 2(Suppl 2):105-113. doi: 10.1111/irv.12089.